Summary
- Current Price
- As of today, OSCR price is $29.65, up +0.17% on
- Current Price All-Time High
- OSCR price is currently -19.86% below its historical high of $37.00 set on
- Market Cap
- OSCR current market cap is $9B, up +92.25% over the past 365 days
- PE Ratio
- OSCR current PE ratio is 21.65
- Revenue
- OSCR current annual revenue is $11.70B, up +27.50% year-over-year
- Next Earnings
- The next earnings release for OSCR is on
Profile
| Metric | Value |
|---|---|
| Full Name | Oscar Health, Inc. |
| Ticker | NYSE: OSCR |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | hioscar.com |
| Employees | 2,400 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $29.65 | |
| Price, 1D Change | +0.17% | |
| Market Cap | $9B | |
| - | ||
| PE Ratio | 21.65 | |
| Beta | 1.41 | |
| Revenue | $11.70B | |
| Revenue, 1Y Change | +27.50% | |
| EPS | -$1.69 | |
| EPS, 1Y Change | -1,864.79% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$1.69 | |
| EPS Estimate | $1.91 | N/A |
| EPS Est. Change | +213.26% | N/A |
| Revenue | $11.70B | |
| Revenue Estimate | $18.73B | N/A |
| Revenue Est. Change | +60.08% | N/A |
| Current Price | $29.65 | |
| Price Target | $33.50 | - |
| Price Tgt. Change | +12.98% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.09 | $0.10 | +4.59% | |
| -$1.29 | -$1.69 | -31.38% | |
| $1.91 | N/A | +213.26% | |
| $2.17 | N/A | +228.22% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $9.26B | $9.18B | -0.86% | |
| $12.02B | $11.70B | -2.64% | |
| $18.73B | N/A | +60.08% | |
| $20.80B | N/A | +77.71% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +60.97% | |
| Price, 3Y | +435.20% | |
| Market Cap, 1Y | +92.25% | |
| Market Cap, 3Y | +644.40% | |
| Revenue, 1Y | +27.50% | |
| Revenue, 3Y | +195.22% | |
| EPS, 1Y | -1,864.79% | |
| EPS, 3Y | +40.81% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $29.65 | |
| SMA 200 | $21.64 | |
| SMA 50 | $30.71 | |
| EMA 200 | $24.23 | |
| EMA 50 | $30.38 | |
| MACD | -$0.26 | |
| Beta | 1.41 | |
| ATR | $1.77 | |
| 14-Day RSI | 42.48 | |
| 10-Day Volatility | 36.87% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $11.70B | |
| EPS | -$1.69 | |
| Gross Profit | $0.00 | |
| Gross Margin | 0.00% | |
| Operating Income | -$396.36M | |
| Operating Margin | -3.39% | |
| Net Income | -$442.90M | |
| Net Margin | -3.79% | |
| EBITDA | -$408.41M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.44 | |
| 0.95 | ||
| - | ||
| - | ||
| 5 | ||
| 1.91 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 21.65 | |
| 0.60 | ||
| 4.46 | ||
| 8.91 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $977.65M | |
| $2.77B | ||
| $6.23B | ||
| $4.51B | ||
| $5.24B | ||
| $4.76B | ||
| Total Debt | $430.10M | |
| $0.00 | ||
| $653.30M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $12.14B | ||
| $396.36M | ||
| - | ||
| $0.00 | ||
| $28.89M | ||
| $0.00 | ||
| $5.61M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $1.09B | ||
| -$241.06M | ||
| $399.21M | ||
| Capex | $36.37M | |
| $1.06B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Raymond James | → | |
| Stephens & Co. | → | |
| B of A Securities | → | |
| Barclays | → | |
| Baird | → | |
| Wells Fargo | → | |
| UBS | → | |
| Barclays | → | |
| Barclays | → | |
| Barclays | → |
Analyst sentiment
Institutional ownership
No data
Screeners with OSCR
FAQ
- What is the ticker symbol for Oscar Health, Inc.?
- The ticker symbol for Oscar Health, Inc. is NYSE:OSCR
- Does Oscar Health, Inc. pay dividends?
- No, Oscar Health, Inc. does not pay dividends
- What sector is Oscar Health, Inc. in?
- Oscar Health, Inc. is in the Healthcare sector
- What industry is Oscar Health, Inc. in?
- Oscar Health, Inc. is in the Healthcare Plans industry
- What country is Oscar Health, Inc. based in?
- Oscar Health, Inc. is headquartered in United States
- When did Oscar Health, Inc. go public?
- Oscar Health, Inc. initial public offering (IPO) was on March 3, 2021
- Is Oscar Health, Inc. in the S&P 500?
- No, Oscar Health, Inc. is not included in the S&P 500 index
- Is Oscar Health, Inc. in the NASDAQ 100?
- No, Oscar Health, Inc. is not included in the NASDAQ 100 index
- Is Oscar Health, Inc. in the Dow Jones?
- No, Oscar Health, Inc. is not included in the Dow Jones index
- When was Oscar Health, Inc. last earnings report?
- Oscar Health, Inc.'s most recent earnings report was on August 6, 2026
- When does Oscar Health, Inc. report earnings?
- The next expected earnings date for Oscar Health, Inc. is November 9, 2026
Data Sources & References
- OSCR Official Website www.hioscar.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1568651/000156865126000011/0001568651-26-000011-index.htm
- OSCR Profile on Yahoo Finance finance.yahoo.com/quote/OSCR
- OSCR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/oscr
